perhaps, but the real barrier is coming up with patented tech that is going to have efficacy. The research will still need to be done and all the associated expense and time, it's just the approval aspects might be less stringent.
Clarification from one of the forum bio scientists would good.
- Forums
- ASX - By Stock
- MSB
- ph1 ..then directly to commercialization
ph1 ..then directly to commercialization, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
-0.045(2.98%) |
Mkt cap ! $1.672B |
Open | High | Low | Value | Volume |
$1.45 | $1.50 | $1.45 | $8.307M | 5.669M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 151320 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 55652 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 150820 | 1.450 |
3 | 79013 | 1.445 |
7 | 113979 | 1.440 |
2 | 54852 | 1.435 |
4 | 159188 | 1.430 |
Price($) | Vol. | No. |
---|---|---|
1.470 | 55652 | 2 |
1.475 | 137352 | 3 |
1.480 | 27852 | 2 |
1.485 | 19000 | 2 |
1.490 | 1000 | 1 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |